Baylor College of Medicine’s Center for Precision Medicine Models has received a five-year, $10 million grant from the ...

The complex molecular underpinnings of genetic and rare diseases offer a promising avenue for scientific exploration and ...

For a long time, evolutionary biologists have thought that the genetic mutations that drive the evolution of genes and ...

The field of insect molecular genetics and physiology explores the complex genetic and biochemical networks that govern insect development, adaptation and homeostasis. With Drosophila melanogaster as ...

CNDP enzymes—carnosinase-1 (CNDP1) and carnosinase-2 (CNDP2)—are zinc-dependent metalloproteinases central to the metabolism ...

For decades, excessive, unscientific regulation has slowed innovation using molecular genetic engineering. Policymakers must awaken to the realization that regulations based on pseudoscience or ...

Molecular and genetic testing has become a game-changer in brain tumor care—shaping diagnosis, guiding treatments and opening ...

Chemo and surgery failed to treat Diane Davis' advanced cancer. Things seemed hopeless until genetic testing found an ...

Genetic counsellors are equipped to discuss the likelihood of having a genetic condition based on an individual’s personal or ...

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...

A rare disorder called myotonic dystrophy type 1 (DM1) causes weakness and muscle loss that gets progressively worse. Patients with DM1 are about 14 times more likely to be diagnosed with autism ...